| http://purl.uniprot.org/citations/11986213 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/11986213 |
| http://purl.uniprot.org/uniprot/#_P02679-citation-11986213 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/11986213 |
| http://purl.uniprot.org/citations/11986213 | http://purl.org/dc/terms/identifier | "doi:10.1182/blood.v99.10.3597"xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/author | "George P.M."xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/11986213 |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/author | "Ganly P.S."xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/volume | "99"xsd:string |
| http://purl.uniprot.org/uniprot/P02679#attribution-6357FB64BC76F541C6663C80ECE9F411 | http://purl.uniprot.org/core/source | http://purl.uniprot.org/citations/11986213 |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/name | "Blood"xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/date | "2002"xsd:gYear |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/pages | "3597-3601"xsd:string |
| http://purl.uniprot.org/uniprot/P02679 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/11986213 |
| http://purl.uniprot.org/citations/11986213 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/author | "Mullin J.L."xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/author | "Brennan S.O."xsd:string |
| http://purl.uniprot.org/citations/11986213 | http://purl.uniprot.org/core/title | "Fibrinogen Hillsborough: a novel gamma-gly309asp dysfibrinogen with impaired clotting."xsd:string |